Murphy et al. observed dramatically higher colorectal cancer risk in ATBC participants with low circulating total ghrelin concentrations in samples collected within 10 years prior to case diagnosis (OR: 10.86, 95% CI 5.01 to 23.55), whereas an inverse association was observed at longer follow-up times. The gene discussed is GHRL; the disease is colorectal cancer.